Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background

Although diuretic-induced Acute Pancreatitis (AP) cases are typically mild to moderate, severe and potentially fatal occurrences can arise.

Case Series and Literature Review

We have, herein, presented a series of diuretic-induced AP cases from March 2018 to February 2024 of a 54-year-old woman treated with chlorthalidone, a 45-year-old male treated with hydrochlorothiazide, and a 48-year-old male treated with frusemide. The literature search has identified 26 cases published to date, 10 from frusemide and 16 from thiazide diuretics. The Naranjo adverse reaction probability scale has categorized all three drugs as “probable”. All cases have responded to conservative treatment and cessation of the offending drug. Various mechanisms, such as hypersensitization, ischemia, direct cytotoxic effects, hypercalcemia, and dose-dependent idiosyncrasy, have been found to lead to intrapancreatic activation of pancreatic enzymes, resulting in drug-induced AP.

Conclusion

Further research into the mechanisms and genetic factors contributing to diuretic-induced AP is essential for enabling early diagnosis and management of diuretic-induced AP.

Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863324787240916114833
2024-10-02
2025-09-08
Loading full text...

Full text loading...

References

  1. SekimotoM. TakadaT. KawaradaY. JPN guidelines for the management of acute pancreatitis: Epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis.J. Hepatobiliary Pancreat. Surg.2006131102410.1007/s00534‑005‑1047‑3 16463207
    [Google Scholar]
  2. PatelM.L. ShyamR. AtamV. BhartiH. SachanR. PariharA. Clinical profile, etiology, and outcome of acute pancreatitis: Experience at a tertiary care center.Ann. Afr. Med.202221211812310.4103/aam.aam_83_20 35848642
    [Google Scholar]
  3. PorgesT. ShafatT. SagyI. Clinical characteristics and prognosis of idiopathic acute pancreatitis.Rambam Maimonides Med. J.2021123e001910.5041/RMMJ.10442 34270401
    [Google Scholar]
  4. ShahP.B. SoundararajanP. SathiyasekaranB.W.C. HegdeS.C. Diuretics for people with chronic kidney disease.Cochrane Libr.201720171010.1002/14651858.CD011339.pub2
    [Google Scholar]
  5. LankischP.G. DrögeM. GotteslebenF. Drug induced acute pancreatitis: Incidence and severity.Gut199537456556710.1136/gut.37.4.565 7489946
    [Google Scholar]
  6. BadalovN. BaradarianR. IswaraK. LiJ. SteinbergW. TennerS. Drug-induced acute pancreatitis: An evidence-based review.Clin. Gastroenterol. Hepatol.200756648661.e310.1016/j.cgh.2006.11.023 17395548
    [Google Scholar]
  7. JohnstonD.H. CornishA.L. Acute pancreatitis in patients receiving chlorothiazide.J. Am. Med. Assoc.1959170172054205610.1001/jama.1959.03010170016003 13672798
    [Google Scholar]
  8. MinkowitzS. SolowayH.B. HallJ.E. YermakovV. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancyObstetrics and Gynecology196424333734210.1097/00006250‑196409000‑00002 14207327
    [Google Scholar]
  9. WilsonA.E. MehraS.K. GomersallC.R. DaviesD.M. Acute pancreatitis associated with frusemide therapy.Lancet1967289748110510.1016/S0140‑6736(67)92499‑3 4163049
    [Google Scholar]
  10. JonesP.E. OelbaumM.H. Frusemide-induced pancreatitis.BMJ19751595013313410.1136/bmj.1.5950.133 1111717
    [Google Scholar]
  11. StrungeP. Letter: Frusemide-induced pancreatitis?BMJ19753598043410.1136/bmj.3.5980.434‑b 1156804
    [Google Scholar]
  12. CallT. MalarkeyW.B. ThomasF.B. Acute pancreatitis secondary to furosemide with associated hyperlipidemia.Am. J. Dig. Dis.197722983583810.1007/BF01694517 900101
    [Google Scholar]
  13. BuchananN. CaneR.D. Frusemid-induced pancreatitis.BMJ197726099141710.1136/bmj.2.6099.1417‑c 589243
    [Google Scholar]
  14. PicklemanJ. StrausF.H.II PaloyanE. Pancreatitis associated with thiazide administration. A role for the parathyroid glands?Arch. Surg.197911491013101610.1001/archsurg.1979.01370330035006 485830
    [Google Scholar]
  15. WeaverG.A. BordleyJ.I.V. GuineyW.B. D’AccurzioA. Chronic pancreatitis with cyst formation after prednisone and thiazide treatment.Am. J. Gastroenterol.1982773164168 7081177
    [Google Scholar]
  16. EckhauserM.L. DoklerM. ImbemboA.L. Diuretic-associated pancreatitis: A collective review and illustrative cases.Am. J. Gastroenterol.1987829865870 3631033
    [Google Scholar]
  17. StenvinkelP. AlvestrandA. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency.Acta Med. Scand.19882241899110.1111/j.0954‑6820.1988.tb16743.x 2458013
    [Google Scholar]
  18. RionR.J. Recurrent pancreatitis after treatment with hydrochlorothiazide.J. Am. Board Fam. Pract.1994717476 7510925
    [Google Scholar]
  19. JuangP. PageR.L.II ZoltyR. Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient.Ann. Pharmacother.200640112813410.1345/aph.1G314 16352777
    [Google Scholar]
  20. BedrossianS. VahidB. A case of fatal necrotizing pancreatitis: Complication of hydrochlorothiazide and lisinopril therapy.Digestive Diseases and Sciences200752255856010.1007/s10620‑006‑9220‑3
    [Google Scholar]
  21. ChaoC.T. ChaoJ.Y. Case report: Furosemide and pancreatitis: Importance of dose and latency period before reaction.Can. Fam. Physician20135914345 23341658
    [Google Scholar]
  22. ChaabanN. KshatriyaS. Thiazide-induced pancreatitis.Kans. J. Med.202215222022110.17161/kjm.vol15.16534 35762001
    [Google Scholar]
  23. MathialaganK SarpongK N MuralidharanK GopalratnamK. S1762 loop diuretic-induced pancreatitisOff J Am Coll Gastroenterol | ACG202211710Se1240110.14309/01.ajg.0000863688.44544.1e
    [Google Scholar]
  24. DenkerP.S. DimarcoP.E. Exenatide (exendin-4)-induced pancreatitis: A case report.Diabetes Care200629247110.2337/diacare.29.02.06.dc05‑2043 16443920
    [Google Scholar]
  25. ElandI.A. SundströmA. VeloG.P. Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP).Scand. J. Gastroenterol.200641121484149010.1080/00365520600761676 17101581
    [Google Scholar]
  26. GriesbacherT. Kallikrein-kinin system in acute pancreatitis: Potential of B(2)-bradykinin antagonists and kallikrein inhibitors.Pharmacology200060311312010.1159/000028355 10754447
    [Google Scholar]
  27. FrickT.W. SpeiserD.E. BimmlerD. LargiadèrF. Drug-induced acute pancreatitis: Further criticism.Dig. Dis.199311211313210.1159/000171405 8339461
    [Google Scholar]
  28. RünziM. LayerP. Drug-associated pancreatitis.Pancreas199613110010910.1097/00006676‑199607000‑00014 8783341
    [Google Scholar]
  29. KanbayM. SelcukH. YìlmazU. BoyaciogluS. Recurrent acute pancreatitis probably secondary to lisinopril.South. Med. J.200699121388138910.1097/01.smj.0000251413.20573.ad 17233197
    [Google Scholar]
/content/journals/cds/10.2174/0115748863324787240916114833
Loading
/content/journals/cds/10.2174/0115748863324787240916114833
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test